Avantor, Inc. (AVTR)

Market Cap	7.68B
Revenue (ttm)	6.58B
Net Income (ttm)	-82.20M
Shares Out	681.81M
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	12.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,062,111
Open	11.20
Previous Close	11.17
Day's Range	10.94 - 11.29
52-Week Range	10.62 - 23.32
Beta	0.93
Analysts	Buy
Price Target	15.31 (+35.91%)
Earnings Date	Oct 29, 2025

About AVTR

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education an...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 17, 2019
• Employees: 13,500
• Stock Exchange: NYSE
• Ticker Symbol: AVTR
• Website: https://www.avantorsciences.com

Financial Performance

In 2024, Avantor's revenue was $6.78 billion, a decrease of -2.64% compared to the previous year's $6.97 billion. Earnings were $711.50 million, an increase of 121.58%.

Analyst Summary

According to 13 analysts, the average rating for AVTR stock is "Buy." The 12-month stock price target is $15.31, which is an increase of 35.91% from the latest price.

Price Target

$15.31

(35.91% upside)

Analyst Consensus: Buy